FIELD: medicine, ophthalmology. SUBSTANCE: substance containing heparin has additionally copper ions, keratan sulfate, chondroitin sulfate at the following ratio of components (mcg/ml) in 0.15 M phosphate buffer (pH = 7.4): heparin 400-800; Cu++ 1-5; keratan sulfate 37.5-375, and chondroitin sulfate 12.5-125. Substance activates cornea endothelium proliferation and metabolism in connective cornea tissue, inhibits inflammation processes development in it. EFFECT: enhanced effectiveness of substance.
Title | Year | Author | Number |
---|---|---|---|
SOLUTION FOR STIMULATING PROLIFERATION OF CORNEA ENDOTHELIUM | 1993 |
|
RU2077878C1 |
METHOD OF RESTORING DAMAGED ENDOTHELIUM OF CORNEA | 1995 |
|
RU2122383C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING CORNEAL EDEMAS | 2001 |
|
RU2197923C1 |
METHOD FOR ACTIVATING CORNEA ENDOTHELIUM PROLIFERATION BY APPLYING GLECOMEN SOLUTION | 1999 |
|
RU2151580C1 |
IRRIGATIVE COMPOSITION "GIDROELASTIC" FOR INTRAOCULAR APPLICATION | 2001 |
|
RU2212883C2 |
PHARMACEUTICAL COMPOSITION FOR MEDICINAL PUPIL OF EYE MYDRIASIS IN OPHTHALMOLOGY | 1999 |
|
RU2148404C1 |
PHARMACEUTICAL COMPOSITION FOR ANESTHESIA IN OPHTHALMOLOGY | 1999 |
|
RU2147876C1 |
METHOD FOR REPAIRING CORNEAL ENDOTHELIUM | 2000 |
|
RU2165749C1 |
METHOD FOR EXTRACTING CATARACT WITH ARTIFICIAL EYE LENS IMPLANTATION | 1997 |
|
RU2149612C1 |
METHOD OF MEDICATIVE MYDRIASIS IN OPHTHALMOLOGY | 1998 |
|
RU2172151C2 |
Authors
Dates
1997-04-20—Published
1995-11-14—Filed